webinar register page

Educational Events Webinar
LIVE Webinar: Back by Popular Demand - KRAS G12C Mutation: An Emerging Biomarker for NSCLC, 5/4/21
Sponsored by Amgen(R)

Program objectives
At the conclusion of this program, participants will be able to
• Discuss the evolution of biomarkers in NSCLC
• Describe KRAS and KRAS G12C prevalence information
• Explain diagnostic strategies and options for KRAS G12C testing

Dr. Fesko and Dr. Hooper will again review the science behind the KRAS G12C emerging biomarker. In case you missed it when it originally ran in December, we are holding this important webinar again on May 4, 2021.

May 4, 2021 12:00 PM in Eastern Time (US and Canada)

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Yuri Fesko, MD
Chief Clinical Officer, Oncology @Quest Diagnostics
Kari Hooper, MD
Pathologist, AmeriPath(R) / Quest Diagnostics; Department Chair, Integris Baptist Medical Center, Oklahoma City, Oklahoma